Friday, February 7, 2025
spot_img

Cipla to scale up Remdesivir production 2-fold

Date:

Share post:

spot_img
spot_img

 


NEW DELHI, April 13: Pharmaceutical company Cipla on Tuesday said it has scaled up the production of remdesivir by 2 times from the last wave of the pandemic.

As the demand for the drug surges, the government has prohibited the exports of remdesivir injection and its active pharmaceutical ingredients (API).

“Given the unprecedented demand for the drug, we have now further ramped up our capacities through our network, to service the demand,” the company said in a statement.

“To ensure fair and equitable access, we are working with the regulatory authorities to restrict supply of the drug only to hospital channels and especially those regions with high burden of severe Covid-19,” Cipla said.

On Tocilizumab, the company said that given the spike in cases and surge in demand, it is facing a shortage and working closely with its partner in taking necessary steps to ensure availability of the drug.

“We expect intermittent supplies as the demand outstrips supply with some more receipts at the earliest,” it added.

spot_img
spot_img

Related articles

Arunachal Christian body to launch stir against 46-year-old anti-conversion law

Itanagar, Feb 6: The Arunachal Christian Forum (ACF), an apex Christian body in the border state, on Thursday...

1st ODI: Gill, Iyer, and Patel fifties help India outplay England by four wickets

Nagpur, Feb 6:  Shubman Gill missed a well-deserved century but shared big partnerships with Shreyas Iyer (59) and...

Israel orders army to prepare ‘voluntary departure’ plan for Gazans following US relocation proposal

Jerusalem, Feb 6: Israeli Defence Minister Israel Katz has ordered the army to prepare a plan to allow...

Rajnath Singh and Hegseth explore ways to deepen defence ties ahead of PM Modi’s US visit

New Delhi/Washington, Feb 6:  Defence Minister Rajnath Singh on Thursday spoke with US Secretary of Defence Pete Hegseth...